Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

A Contract Award Notice
by UK HEALTH SECURITY AGENCY

Source
Contracts Finder
Type
Contract (Products)
Duration
4 year
Value
£1
Sector
HEALTH
Published
29 Aug 2025
Delivery
01 Oct 2025 to 30 Sep 2029
Deadline
10 Mar 2025 13:00

Concepts

Location

Geochart for 1 buyers and 2 suppliers

Description

Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this procurement. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Award Detail

1 Merck Sharpe & Dohme (London)
  • Value: £1
2 Glaxosmithkline (London)
  • Value: £1

CPV Codes

  • 33651600 - Vaccines

Other Information

Award documents MMRV Award documents MMRV.zip

Reference

Domains